B Braun Medical Inc: Dextrose Injection Usp, 70%
Recall Summary B. Braun Medical Inc. is recalling Dextrose Injection USP 70% in 2000 mL bags nationwide because the product may leak from the diaphragm port after the foil is removed, which could compromise sterility. This is a prescription-only injectable medication distributed across all U.S. states. The recall was classified as Class II, meaning the product could cause adverse health effects but is unlikely to cause serious injury.
- Recalling firm
- B BRAUN MEDICAL INC
- Product
- DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
- Reason
- Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-04-02
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/76e7497b-ebc1-4634-a27e-409bd0ed1486